No glycemic benefit from guar administration in NIDDM.
A randomized crossover study of 5-g guar minitablets against placebo, given three times per day with main meals for 8 wk, was done in 29 non-insulin-dependent diabetes mellitus (NIDDM) patients who had near-normal fasting plasma glucose concentrations on treatment with diet alone, additional sulfony...
Päätekijät: | Holman, R, Steemson, J, Darling, P, Turner, R |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
1987
|
Samankaltaisia teoksia
-
LACK OF BENEFIT FROM GUAR ADMINISTRATION IN WELL CONTROLLED NON-INSULIN-DEPENDENT DIABETIC-PATIENTS
Tekijä: Holman, R, et al.
Julkaistu: (1984) -
Insulin use in NIDDM. Rationale based on pathophysiology of disease.
Tekijä: Turner, R, et al.
Julkaistu: (1990) -
Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
Tekijä: Cull, C, et al.
Julkaistu: (1997) -
Effects of ethnicity on metabolic control during the first six years of NIDDM
Tekijä: Davis, T, et al.
Julkaistu: (1997) -
Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
Tekijä: Turner, R, et al.
Julkaistu: (1997)